VALN
NASDAQ
$4.93
Valneva SE (VALN)
Valneva SE, a company specialized in vaccines, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. The company is headquartered in Saint-Herblain, France.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $12.20 (+147.46%)
Market Cap
$441M
Free Cash Flow Yield
-18.88%
Beta (5Y)
0.97
Price Chart
Valuation
Market Cap$441M
Forward P/E666.67
P/S3.35
P/B6.01
Profitability
Total Revenue (TTM)$181M
Gross Profit (TTM)-$46M
EBITDA-$90M
Profit Margin-88.3%
Operating Margin-76.7%
EPS-$1.89
Financial Health
Debt-to-Equity273.2%
Free Cash Flow Yield-18.88%
Growth & Risk
EPS 5Y CAGR-3.75%
Revenue 5Y CAGR+9.35%
Beta (5Y)0.97
Sharpe Ratio-0.05